Almasan AG
  • Landing
  • Home
  • About
  • Portfolio
  • Services
  • Insights
  • Contact
  • Cookie Policy (EU)
Select Page

Dive in: Gaining long-term leadership in a therapy area can be commercially invaluable

by Aleksandar Ruzicic | Sep 2, 2024 | Business Optimization

Therapeutic area leadership was once defined simply by who had the biggest and best drug for that condition; the level of leadership could usually be measured by sales figures, but times have changed. Individual products are still undoubtedly the most important...

Five Steps to Find your ‘Beyond the Pill’ Strategy

by Aleksandar Ruzicic | Aug 19, 2024 | Business Optimization

Outcommes data are the holy grail of drug development and market access. Everyone involved in healthcare – physicians, patients, governments and in particular payers – wants to see incontestable proof that the introduction of a new drug will result in meaningful and...

Uptake challenges: Are healthcare systems ready for personalized medicines and companion diagnostics?

by Aleksandar Ruzicic | Aug 14, 2024 | Patient Access

Although the number of personalised medicines is increasing, many countries are not set up to jointly assess both the medicine and its companion diagnostic, leading to lower reimbursement prices and slower product uptake. In some countries, patients do not even get...

2nd Global Medtech Industry Report: Accelerating Transformation for Success

by Aleksandar Ruzicic | Aug 9, 2024 | Medtech

Since publishing our first Global Medtech Industry Report, the healthcare environment has continued its rapid pace of change. The changing environment continues to hit the bottom-line of Medtech companies. Medtech executives have to cope with a multi-strategy world....

New shores: The shift from just selling pills to developing value-added services has only just begun

by Aleksandar Ruzicic | Jul 24, 2024 | Business Optimization

The case for ‘beyond the pill’ services is becoming well established. Most new drugs coming to market are perceived by some to have relatively limited value in their own right (eg incremental benefits over existing options). Some of the most urgent unmet needs in...
« Older Entries
Next Entries »
    Website built by The Free Website Guys🚀
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
    View preferences
    {title} {title} {title}